Munich, Germany; Zurich, Switzerland; Tuebingen, Germany; São Paulo and Rio de Janeiro, Brazil; and Albany, N.Y.
From the Department for Hand, Plastic and Aesthetic Surgery, Ludwig-Maximilian University Munich; private practice; the Division of Thoracic Surgery, University Hospital Zurich; Institute of Neuroanatomy & Developmental Biology (INDB), Eberhard Karls University Tuebingen; Clinica Vida; private practice; and the Department of Medical Education, Albany Medical College.
Plast Reconstr Surg. 2018 May;141(5):650e-662e. doi: 10.1097/PRS.0000000000004211.
To retrospectively evaluate the rate of adverse events after hand volumizing procedures using a calcium hydroxylapatite product and to investigate the relationship between injector used (i.e., needle versus cannula) and technique applied (i.e., bolus, tenting, proximal-to-distal fanning, distal-to-proximal single line).
Two hundred twenty individuals, including 214 women (97.3 percent) aged 52.3 ± 11.4 years, treated bilaterally for hand rejuvenation were investigated between the years 2006 and 2017. Cadaveric dissections (n = 12), fluoroscopic (n = 4), ultrasound (n = 22), and computed tomographic (n = 4) imaging were also performed to guide conclusions.
Thirty-two of 440 hands (7.3 percent) developed adverse events within the first 15 days, with swelling in 11 (5 percent), pain in four (1.8 percent), erythema in three (1.4 percent), and discoloration in one (0.5 percent). Using a needle (versus a cannula) was significantly related to the occurrence of adverse events (OR, 7.57; 95 percent CI, 3.76 to 15.24; p < 0.001). The proximal-to-distal fanning technique with access to the dorsal superficial lamina was identified as a safer application technique, with each of the other techniques having a significantly increased odds ratio for adverse events: bolus technique (OR, 26.9; 95 percent CI, 6.87 to 105.2; p < 0.001), tenting technique (OR, 24.73; 95 percent CI, 7.48 to 81.76; p < 0.001), and single-line technique (OR, 26.68; 95 percent CI, 7.45 to 95.48; p < 0.001).
The results of this study support the use of cannula versus needle and the proximal-to-distal fanning technique. The underlying anatomy supports the positioning of the material into the subdermal space, which can be identified less than 1 mm deep to the skin surface, and is termed the dorsal superficial lamina.
回顾性评估使用钙羟磷灰石产品进行手部容积增大手术后的不良事件发生率,并研究使用的注射器(即针与套管)和应用的技术(即团注、帐篷状隆起、从近端到远端扇形分布、从远端到近端单线分布)之间的关系。
在 2006 年至 2017 年期间,对 220 名双侧接受手部年轻化治疗的个体(214 名女性,占 97.3%,年龄 52.3 ± 11.4 岁)进行了研究。还进行了尸体解剖(n=12)、荧光透视(n=4)、超声(n=22)和计算机断层扫描(n=4)成像以指导结论。
在最初的 15 天内,440 只手中的 32 只(7.3%)发生了不良事件,其中肿胀 11 只(5%),疼痛 4 只(1.8%),红斑 3 只(1.4%),变色 1 只(0.5%)。使用针(而非套管)与不良事件的发生显著相关(OR,7.57;95%CI,3.76 至 15.24;p<0.001)。从近端到远端扇形分布技术,进入背侧浅筋膜层,被确定为一种更安全的应用技术,其他每种技术的不良事件发生的优势比均显著增加:团注技术(OR,26.9;95%CI,6.87 至 105.2;p<0.001)、帐篷状隆起技术(OR,24.73;95%CI,7.48 至 81.76;p<0.001)和单线技术(OR,26.68;95%CI,7.45 至 95.48;p<0.001)。
本研究结果支持使用套管而非针和从近端到远端扇形分布技术。基础解剖学支持将材料置于皮下空间中的定位,该空间可以在距皮肤表面不到 1 毫米的深度处识别,被称为背侧浅筋膜层。